This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Oncotab, Inc., The University of North Carolina at Charlotte. Active years: 2023.
Company Filing History:
1 out of 1 
1 out of 224 Years Active: 2023
Title: Yan He - Innovator in Tumor-Specific Antibody Conjugates
Introduction
Yan He is a prominent inventor based in Hayward, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of tumor-specific antibody conjugates. His work focuses on creating innovative solutions for cancer treatment.
Latest Patents
Yan He holds a patent for "Tumor specific antibody conjugates and uses therefor." This patent includes antibodies, fragments, derivatives, and nanoparticle conjugates that specifically bind to tumor antigens. The patent also covers nucleic acid molecules encoding chimeric antigen receptors (CARs) that target tumor antigens. These innovations aim to enhance anti-tumor immunity and improve treatment outcomes for patients with MUC1-associated diseases.
Career Highlights
Throughout his career, Yan He has worked with notable organizations such as Oncotab, Inc. and the University of North Carolina at Charlotte. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Yan He has collaborated with esteemed colleagues, including Pinku Mukherjee and Jordon Wang. These partnerships have fostered a collaborative environment that promotes innovation and research in the field of cancer treatment.
Conclusion
Yan He's contributions to the development of tumor-specific antibody conjugates represent a significant advancement in cancer therapy. His innovative work continues to inspire future research and development in the biotechnology sector.